Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) PT Raised to $26 at Oppenheimer Following Solid 4Q

February 3, 2017 9:47 AM
Oppenheimer raised its price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.00) while maintaining a Perform rating following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles